spot difference
  • Sign In
  • Register
  • Cart (0)
Home > References > 2017 > Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

Frederick L.Locke, Sattva S. Neelapu, Nancy L.Bartlett, Tanya Siddiqi, Julio C.Chavez, Chitra M.Hosing, Armin Ghobadi, Lihua E.Budde, Adrian Bot, John M.Rossi, Yizhou Jiang, Allen X.Xue, Meg Elias, Jeff Aycock, Jeff Wiezorek, William Y.Go
Journal   Molecular Therapy
Species  
Analytes Measured  
Matrix Tested  
Year   2017
Volume   25
Page Numbers   285-295
Application   , Oncology and Cancer , Angiogenesis and Vascular , Inflammation

View Publications
View Publications

Related Products

V-PLEX Plus Cytokine Panel 1 Human Kit
GM-CSF, IL-1α, IL-5, IL-7, IL-12/IL-23p40, IL-15, IL-16, IL-17A, TNF-β, VEGF-A | Human
Multiplex
NEW
V-PLEX Cytokine Panel 1 Human Kit
GM-CSF, IL-1α, IL-5, IL-7, IL-12/IL-23p40, IL-15, IL-16, IL-17A, TNF-β, VEGF-A | Human
Multiplex
NEW
V-PLEX Plus Proinflammatory Panel 1 Human Kit
IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-13, TNF-α | Human
Multiplex
NEW
V-PLEX Proinflammatory Panel 1 Human Kit
IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-13, TNF-α | Human
Multiplex
NEW
Browse Our Products

By Analytes
By Applications
Search
Customer Service/Orders


Scientific/Technical Support


Instrument Support


Company Headquarters